69660-201 : Rubraca 200 mg Oral Tablet, Film Coated


NDC69660-201
Labeler: Clovis Oncology, Inc.
Product Type: Human Prescription Drug
Drug Name:  Rubraca
Dosage Form: Oral Tablet, Film Coated
Application #: NDA209115
Rev. Date: 


Appearance:


Markings: C2
Shapes:  Round
Colors:  Blue
Size (mm): 11
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 69660-201-91: 60 TABLET, FILM COATED IN 1 BOTTLE (69660‑201‑91)

Active Ingredients:

  • Rucaparib Camsylate

Dosage Strength:

  • 200 mg

Inactive Ingredients:

  • Cellulose, Microcrystalline
  • Sodium Starch Glycolate Type a Potato
  • Silicon Dioxide
  • Magnesium Stearate
  • Polyvinyl Alcohol, Unspecified
  • Titanium Dioxide
  • Polyethylene Glycol, Unspecified
  • Talc
  • Fd&c Blue No. 1
  • Fd&c Blue No. 2

Pharmaceutical Classes:

  • Poly(ADP-Ribose) Polymerase Inhibitor [EPC]
  • Poly(ADP-Ribose) Polymerase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 69660-202 Rubraca 250 mg Oral Tablet, Film Coated by Clovis Oncology, Inc.
  • 69660-203 Rubraca 300 mg Oral Tablet, Film Coated by Clovis Oncology, Inc.
  • 82154-0783 Rubraca 200 mg Oral Tablet, Film Coated by Zr Pharma & Gmbh
  • 82154-0784 Rubraca 250 mg Oral Tablet, Film Coated by Zr Pharma & Gmbh
  • 82154-0785 Rubraca 300 mg Oral Tablet, Film Coated by Zr Pharma & Gmbh

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 69660-201 QR Code

< Prev: 69658-101Next: 69660-202 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.